Wise AI Nears Completion of Technology Special Case 'Preliminary Technical Evaluation'... "Confident in Doubling Sales This Year"

Wise AI, a company specializing in the development of artificial intelligence (AI) platforms listed on K-OTC, announced on the 31st that it is in the final stages of preparing for the preliminary technical evaluation aimed at listing on KOSDAQ through the technology special listing system next year. Wise AI plans to apply for the preliminary evaluation as early as November and quickly proceed with the main evaluation once the assessment is completed.

Wise AI is a company that researches and develops AICP (AI Communication Platform) technology, which enables AI to understand human speech and support smooth communication. The company focuses on providing AI services that anyone can easily utilize. To this end, about 60% of its total workforce is composed of technical development personnel, concentrating on technology development.

Wise AI’s AICP is designed with a modular architecture structure, offering high flexibility and scalability as a key feature. It also enables efficient system operation and independent function management. This allows for rapid response to various business demands.

Wise AI has a diverse product portfolio including △ the on-premises AI customer center (AICC) model ‘SSAM’ △ the cloud-based mass-market SaaS model ‘AiU,’ prepared with institutional investments from IBK, Q Capital, BNW, and GB Ventures △ and ‘DentOn,’ which was launched in May this year and has been introduced and operated in about 80 dental clinics, driving sales growth in the second half of the year. Major customers include large medical institutions, hospitals and clinics, and health screening centers. Recently, the company also entered the franchise market through a contract with ‘Coffee Evanhada.’

In particular, DentOn, strategically launched this year, has rapidly expanded its market share by receiving enthusiastic responses through joint sales, lectures, and participation in academic conference booths based on partnerships with major dental associations such as the Korean Academy of Oral and Maxillofacial Implantology (KAOMI), the Korean Academy of Geriatric Dentistry, the Korean Academy of Prosthodontics, the Korean Association of Orthodontists, as well as various academic societies including the Seoul and Incheon Korean Medicine Associations and the Korean Society of Plastic Surgeons.

Based on the success of DentOn, Wise AI plans to accelerate performance growth by opening a new version of AiU targeting plastic surgery, dermatology, and screening centers on November 5.

Additionally, Wise AI is preparing to obtain CSAP (Cloud Security Assurance Program) certification to enter the public institution market and is also pursuing global market expansion. In fact, this month, as a policy project, the company launched an AI call center PoC in the UK, achieving results such as beginning to accumulate AI training data for customer service in English.

A Wise AI representative stated, “We have been steadily preparing the application for the preliminary technical evaluation with advice from Korea Investment & Securities, the lead underwriter, aiming for a technology special listing.” He added, “Regarding accounting, we are closely collaborating with Samil and Samjong, the two largest accounting firms in Korea, after contracting with them to prepare the designated audit report under the International Financial Reporting Standards (K-IFRS), which is an essential requirement for technology special listing.”

He continued, “Due to changes in accounting standards, some unrecognized sales from contracts signed last year are expected to be recognized as sales this year. When combined with sales generated from consecutive new contracts in the second half, this year’s annual performance is expected to smoothly achieve a ‘double-up’ following last year.”

Meanwhile, Wise AI ultimately aims to grow into a company that leads the realization of social value by utilizing AI technology. The company plans to address welfare blind spots through AI-based telephone care services and AI welfare workers and to challenge the development of ‘digital new drugs’ targeting intractable diseases such as dementia.

This content was produced with the assistance of AI translation services.